首页 > 最新文献

Psychiatry and Clinical Psychopharmacology最新文献

英文 中文
Restless Back Syndrome: A Case Report and Literature Review. 不宁背综合征:病例报告与文献综述
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5152/pcp.2022.22441
Fengli Sun, Hejian Tao, Weidong Jin

Restless back syndrome is characterized by uncomfortable pain, burning, ant crawling, or itching sensations in the back. Restless back syndrome is regarded as a back variant of restless legs syndrome. The lack of specific diagnostic criteria makes it difficult to recognize the restless back syndrome, which is usually neglected in clinical practice. Moreover, when a patient was diagnosed with restless back syndrome, the adjustment of medications was the first choice for doctors, which may make the patient's condition unstable. To describe the restless back syndrome and collect and review the related lecture, and the possible mechanism of restless back syndrome was analyzed. A 50-year-old man was diagnosed with schizophrenia 15 years ago. Starting with 25 mg/day aripiprazole, which was switched to amisulpride 0.6 g/day due to no effectiveness, the patient reported symptoms of restless back syndrome in the 2 weeks since the treatment with 0.6 g/day of amisulpride. With the reduction of amisulpride adjustment, restless back syndrome spontaneously remitted. The central dopaminergic dysfunction may play an important role in the development of restless back syndrome. This case suggests that psychiatrists should pay attention to restless back syndrome when using antipsychotics. Moreover, when a patient manifests restless back syndrome, observation or decreasing medication may be one choice.

背部不宁综合症的特征是背部出现不舒服的疼痛、烧灼感、蚂蚁爬行感或瘙痒感。背部不宁综合征被认为是不宁腿综合征的背部变异。由于缺乏具体的诊断标准,因此很难识别背部不宁综合征,在临床实践中通常会被忽视。此外,当患者被诊断为背部不宁综合征时,调整药物是医生的首选,这可能会使患者的病情不稳定。为了描述背部不宁综合征,并收集和回顾相关讲座,分析背部不宁综合征的可能机制。一名 50 岁的男子 15 年前被诊断患有精神分裂症。患者最初使用阿立哌唑25毫克/天,后因无效改用氨磺必利0.6克/天,在使用氨磺必利0.6克/天治疗2周后,患者报告出现背部不宁综合征症状。随着氨磺必利用量的减少,背部不宁综合征自行缓解。中枢多巴胺能功能障碍可能在不宁背综合征的发生中扮演了重要角色。本病例提示精神科医生在使用抗精神病药物时应注意背部不宁综合征。此外,当患者出现背部不宁综合征时,观察或减少用药可能是一种选择。
{"title":"Restless Back Syndrome: A Case Report and Literature Review.","authors":"Fengli Sun, Hejian Tao, Weidong Jin","doi":"10.5152/pcp.2022.22441","DOIUrl":"10.5152/pcp.2022.22441","url":null,"abstract":"<p><p>Restless back syndrome is characterized by uncomfortable pain, burning, ant crawling, or itching sensations in the back. Restless back syndrome is regarded as a back variant of restless legs syndrome. The lack of specific diagnostic criteria makes it difficult to recognize the restless back syndrome, which is usually neglected in clinical practice. Moreover, when a patient was diagnosed with restless back syndrome, the adjustment of medications was the first choice for doctors, which may make the patient's condition unstable. To describe the restless back syndrome and collect and review the related lecture, and the possible mechanism of restless back syndrome was analyzed. A 50-year-old man was diagnosed with schizophrenia 15 years ago. Starting with 25 mg/day aripiprazole, which was switched to amisulpride 0.6 g/day due to no effectiveness, the patient reported symptoms of restless back syndrome in the 2 weeks since the treatment with 0.6 g/day of amisulpride. With the reduction of amisulpride adjustment, restless back syndrome spontaneously remitted. The central dopaminergic dysfunction may play an important role in the development of restless back syndrome. This case suggests that psychiatrists should pay attention to restless back syndrome when using antipsychotics. Moreover, when a patient manifests restless back syndrome, observation or decreasing medication may be one choice.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082566/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80502311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Clinical Features, Serum Lipid, and Uric Acid Levels in Patients with Unipolar Depression and Bipolar Depression. 单相抑郁症和双相抑郁症患者临床特征、血清脂质和尿酸水平的比较。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-12-01 DOI: 10.5152/pcp.2022.22473
Yi Liu, Xiuyue Zhang, Ping Wang, Mei Yang, Na Li

Background: The level of uric acid and serum lipids has been suggested as a possible biomarker of bipolar disorder. We aimed to investigate the differences in clinical features and serum levels of lipids and uric acid in patients with bipolar depression or unipolar depression in order to distinguish them.

Methods: The clinical data of 53 patients with unipolar depression (unipolar group) and 61 patients with bipolar depression (bipolar group), who all met the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders-IV of the American Psychiatric Association, were compared with each other retrospectively. The serum levels of uric acid and lipids (including total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides) were measured after hospital admission. The Statistical Package for the Social Science version 22.0 software was used for statistical analysis, and logistic regression was employed to identify the susceptible factors of bipolar depression.

Results: Taking into account confounding factors, logistic regression analysis revealed that the high levels of uric acid (odds ratio = 1.016, P = .001) and low levels of triglycerides (odds ratio = 0.457, P = .025) were significantly correlated with bipolar depression.

Conclusion: It has been demonstrated from this study that individuals with bipolar depression have higher serum uric acid levels and lower triglyceride levels than unipolar depression ones. Therefore, serum levels of uric acid and triglycerides might have the potential to be the biomarkers for differential diagnosis between bipolar and unipolar depression.

背景:尿酸和血清脂质水平被认为可能是双相情感障碍的生物标志物。我们的目的是研究双相抑郁症和单相抑郁症患者的临床特征、血脂和尿酸水平的差异,以便将它们区分开来:方法:我们对 53 名单相抑郁症患者(单相组)和 61 名双相抑郁症患者(双相组)的临床数据进行了回顾性比较,这些患者均符合美国精神病学协会《精神障碍诊断与统计手册-IV》的诊断标准。入院后测量血清尿酸和血脂(包括总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇和甘油三酯)水平。采用社会科学统计软件包 22.0 版进行统计分析,并通过逻辑回归确定躁郁症的易感因素:考虑到混杂因素,逻辑回归分析表明,尿酸水平高(几率比=1.016,P=0.001)和甘油三酯水平低(几率比=0.457,P=0.025)与躁狂抑郁显著相关:结论:本研究表明,与单相抑郁症患者相比,双相抑郁症患者的血清尿酸水平更高,甘油三酯水平更低。因此,血清尿酸和甘油三酯水平有可能成为鉴别诊断双相抑郁症和单相抑郁症的生物标志物。
{"title":"Comparison of Clinical Features, Serum Lipid, and Uric Acid Levels in Patients with Unipolar Depression and Bipolar Depression.","authors":"Yi Liu, Xiuyue Zhang, Ping Wang, Mei Yang, Na Li","doi":"10.5152/pcp.2022.22473","DOIUrl":"10.5152/pcp.2022.22473","url":null,"abstract":"<p><strong>Background: </strong>The level of uric acid and serum lipids has been suggested as a possible biomarker of bipolar disorder. We aimed to investigate the differences in clinical features and serum levels of lipids and uric acid in patients with bipolar depression or unipolar depression in order to distinguish them.</p><p><strong>Methods: </strong>The clinical data of 53 patients with unipolar depression (unipolar group) and 61 patients with bipolar depression (bipolar group), who all met the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders-IV of the American Psychiatric Association, were compared with each other retrospectively. The serum levels of uric acid and lipids (including total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides) were measured after hospital admission. The Statistical Package for the Social Science version 22.0 software was used for statistical analysis, and logistic regression was employed to identify the susceptible factors of bipolar depression.</p><p><strong>Results: </strong>Taking into account confounding factors, logistic regression analysis revealed that the high levels of uric acid (odds ratio = 1.016, <i>P</i> = .001) and low levels of triglycerides (odds ratio = 0.457, <i>P</i> = .025) were significantly correlated with bipolar depression.</p><p><strong>Conclusion: </strong>It has been demonstrated from this study that individuals with bipolar depression have higher serum uric acid levels and lower triglyceride levels than unipolar depression ones. Therefore, serum levels of uric acid and triglycerides might have the potential to be the biomarkers for differential diagnosis between bipolar and unipolar depression.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082628/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85915959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Direct and Indirect Exposure to Trauma, Posttraumatic Stress Disorder Symptoms, and Poor Subjective Sleep Quality in Patients with Substance Use Disorder. 药物使用障碍患者的直接和间接创伤暴露、创伤后应激障碍症状和主观睡眠质量差。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.22368
Julia Ten Holt, Arnold A P van Emmerik, Peter Blanken, Jesse E Borgdorff, Pieter P C Ten Holt, Rob M Kok, Joanne Mouthaan, Bouwe Pieterse, Julia F Van den Berg

Background: Despite the frequent co-occurrence of posttraumatic stress disorder and substance use disorder, screening for trauma exposure and posttraumatic stress disorder symptoms is not a routine practice in substance use disorder clinics. The aims of this study were to examine the prevalence of exposure to traumatic events, posttraumatic stress disorder symptoms, and subjective sleep quality in substance use disorder inpatients after detoxification. In addition, we analyzed associations of sociodemographics, direct and indirect exposure to traumatic events, and sleep quality with posttraumatic stress disorder symptom severity.

Methods: Adults diagnosed with substance use disorder (n = 188; 25% women, mean age 46.6 ± 12.3 years) from 2 inpatient addiction clinics were assessed at approximately 4 days post-admission for age, gender, educational level, self-reported substance use, trauma exposure, general and posttraumatic stress disorder-specific subjective sleep quality, and posttraumatic stress disorder symptom severity. Correlates of posttraumatic stress disorder symptom severity were identified with linear regression analyses.

Results: The prevalence of direct trauma exposure was high (89%), 51% of participants screened positive for posttraumatic stress disorder and 87% reported clinically significant poor sleep quality. Younger age, female gender, direct and indirect exposure to more traumatic events, and poor subjective sleep quality were associated with more severe posttraumatic stress disorder symptoms.

Conclusion: Nearly all substance use disorder patients admitted for detoxification in our study had been directly or indirectly exposed to 1 or more traumatic events, and many reported posttraumatic stress disorder symptoms and poor sleep quality. Younger and female substance use disorder patients were at higher risk of posttraumatic stress disorder symptoms. Our results emphasize the need for systematic screening for direct and indirect trauma exposure, posttraumatic stress disorder symptoms, and poor sleep quality in patients admitted for clinical substance use disorder treatment.

背景:尽管创伤后应激障碍和药物滥用障碍经常并发,但在药物滥用障碍诊所中,筛查创伤暴露和创伤后应激障碍症状并非常规做法。本研究旨在调查药物使用障碍住院患者在戒毒后的创伤事件暴露、创伤后应激障碍症状和主观睡眠质量的发生率。此外,我们还分析了社会人口统计学、直接和间接接触创伤事件以及睡眠质量与创伤后应激障碍症状严重程度之间的关联:在入院约 4 天后,我们对来自 2 家成瘾住院诊所的被诊断为药物使用障碍的成年人(n = 188;25% 为女性,平均年龄为 46.6 ± 12.3 岁)进行了评估,包括年龄、性别、受教育程度、自我报告的药物使用情况、创伤暴露情况、一般和创伤后应激障碍特异性主观睡眠质量以及创伤后应激障碍症状严重程度。通过线性回归分析确定了创伤后应激障碍症状严重程度的相关因素:结果:直接遭受创伤的比例很高(89%),51%的参与者对创伤后应激障碍筛查呈阳性,87%的参与者报告睡眠质量差有临床意义。年轻、女性、直接或间接遭受更多创伤事件以及主观睡眠质量差与更严重的创伤后应激障碍症状有关:结论:在我们的研究中,几乎所有接受戒毒治疗的药物滥用障碍患者都曾直接或间接遭遇过一次或多次创伤事件,其中许多人都报告了创伤后应激障碍症状和睡眠质量差。年轻和女性药物滥用障碍患者出现创伤后应激障碍症状的风险更高。我们的研究结果表明,有必要对接受临床药物使用障碍治疗的患者进行直接和间接创伤暴露、创伤后应激障碍症状和睡眠质量差的系统筛查。
{"title":"Direct and Indirect Exposure to Trauma, Posttraumatic Stress Disorder Symptoms, and Poor Subjective Sleep Quality in Patients with Substance Use Disorder.","authors":"Julia Ten Holt, Arnold A P van Emmerik, Peter Blanken, Jesse E Borgdorff, Pieter P C Ten Holt, Rob M Kok, Joanne Mouthaan, Bouwe Pieterse, Julia F Van den Berg","doi":"10.5152/pcp.2022.22368","DOIUrl":"10.5152/pcp.2022.22368","url":null,"abstract":"<p><strong>Background: </strong>Despite the frequent co-occurrence of posttraumatic stress disorder and substance use disorder, screening for trauma exposure and posttraumatic stress disorder symptoms is not a routine practice in substance use disorder clinics. The aims of this study were to examine the prevalence of exposure to traumatic events, posttraumatic stress disorder symptoms, and subjective sleep quality in substance use disorder inpatients after detoxification. In addition, we analyzed associations of sociodemographics, direct and indirect exposure to traumatic events, and sleep quality with posttraumatic stress disorder symptom severity.</p><p><strong>Methods: </strong>Adults diagnosed with substance use disorder (n = 188; 25% women, mean age 46.6 ± 12.3 years) from 2 inpatient addiction clinics were assessed at approximately 4 days post-admission for age, gender, educational level, self-reported substance use, trauma exposure, general and posttraumatic stress disorder-specific subjective sleep quality, and posttraumatic stress disorder symptom severity. Correlates of posttraumatic stress disorder symptom severity were identified with linear regression analyses.</p><p><strong>Results: </strong>The prevalence of direct trauma exposure was high (89%), 51% of participants screened positive for posttraumatic stress disorder and 87% reported clinically significant poor sleep quality. Younger age, female gender, direct and indirect exposure to more traumatic events, and poor subjective sleep quality were associated with more severe posttraumatic stress disorder symptoms.</p><p><strong>Conclusion: </strong>Nearly all substance use disorder patients admitted for detoxification in our study had been directly or indirectly exposed to 1 or more traumatic events, and many reported posttraumatic stress disorder symptoms and poor sleep quality. Younger and female substance use disorder patients were at higher risk of posttraumatic stress disorder symptoms. Our results emphasize the need for systematic screening for direct and indirect trauma exposure, posttraumatic stress disorder symptoms, and poor sleep quality in patients admitted for clinical substance use disorder treatment.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099636/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81641476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. 对强迫症患者内源性氧化应激标记物水平的横断面测量。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.21318
Faruk Kurhan, Gülsüm Zuhal Kamış, Hamit Hakan Alp, Emine Füsun Akyüz Çim, Abdullah Atlı

Background: There is a correlation between the increase in reactive oxygen radicals and the presence of specific mental illnesses. In this context, the objective of this study is to investigate the relationship between obsessive-compulsive disorder and the variations in the levels of several endogenous oxidative stress markers.

Methods: Thirty obsessive-compulsive disorder patients were included in the study as the patient group, and 30 healthy volunteers of matching demographic characteristics were included in the study as the control group. Accordingly, the patient group consisted of 10 females and 20 males with a mean age of 29.5 ± 6.1 years, and the control group consisted of 15 females and 15 males with a mean age of 31.9±5.6 years. The serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the 2 groups were compared using the independent samples t-test. The relationships between the serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the 2 groups were analyzed using the Pearson's correlation coefficient.

Results: The serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the patient group were statistically significantly higher than those of the control group (P < .001). Statistically significant positive correlations were detected between the serum nicotinamide adenine dinucleotide phosphate oxidase-2 and nicotinamide adenine dinucleotide phosphate oxidase-4 levels (r = 0.692, P = .001) and between the serum nicotinamide adenine dinucleotide phosphate oxidase-2 and malondialdehyde levels (r = 0.563, P = .001).

Conclusion: The results of this study indicated that oxidative stress and lipid peroxidation levels were higher in obsessive-compulsive disorder patients. Based on this finding, NOX-2 and NOX-4 levels can be used as indicators of endogenous oxidative stress in obsessive-compulsive disorder patients.

背景:活性氧自由基的增加与特定精神疾病之间存在相关性。在此背景下,本研究旨在探讨强迫症与几种内源性氧化应激标志物水平变化之间的关系:研究以 30 名强迫症患者为患者组,以 30 名具有相同人口统计学特征的健康志愿者为对照组。患者组中女性 10 人,男性 20 人,平均年龄(29.5±6.1)岁;对照组中女性 15 人,男性 15 人,平均年龄(31.9±5.6)岁。两组血清烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2、烟酰胺腺嘌呤二核苷酸磷酸氧化酶-4和丙二醛水平的比较采用独立样本t检验。用皮尔逊相关系数分析两组血清烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2、烟酰胺腺嘌呤二核苷酸磷酸氧化酶-4和丙二醛水平之间的关系:结果:患者组的血清烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2、烟酰胺腺嘌呤二核苷酸磷酸氧化酶-4和丙二醛水平明显高于对照组,差异有统计学意义(P < .001)。在血清烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2和烟酰胺腺嘌呤二核苷酸磷酸氧化酶-4水平之间(r = 0.692,P = .001)以及血清烟酰胺腺嘌呤二核苷酸磷酸氧化酶-2和丙二醛水平之间(r = 0.563,P = .001)发现了统计学意义上的正相关:本研究结果表明,强迫症患者的氧化应激和脂质过氧化水平较高。基于这一发现,NOX-2 和 NOX-4 水平可作为强迫症患者内源性氧化应激的指标。
{"title":"A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder.","authors":"Faruk Kurhan, Gülsüm Zuhal Kamış, Hamit Hakan Alp, Emine Füsun Akyüz Çim, Abdullah Atlı","doi":"10.5152/pcp.2022.21318","DOIUrl":"10.5152/pcp.2022.21318","url":null,"abstract":"<p><strong>Background: </strong>There is a correlation between the increase in reactive oxygen radicals and the presence of specific mental illnesses. In this context, the objective of this study is to investigate the relationship between obsessive-compulsive disorder and the variations in the levels of several endogenous oxidative stress markers.</p><p><strong>Methods: </strong>Thirty obsessive-compulsive disorder patients were included in the study as the patient group, and 30 healthy volunteers of matching demographic characteristics were included in the study as the control group. Accordingly, the patient group consisted of 10 females and 20 males with a mean age of 29.5 ± 6.1 years, and the control group consisted of 15 females and 15 males with a mean age of 31.9±5.6 years. The serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the 2 groups were compared using the independent samples <i>t</i>-test. The relationships between the serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the 2 groups were analyzed using the Pearson's correlation coefficient.</p><p><strong>Results: </strong>The serum nicotinamide adenine dinucleotide phosphate oxidase-2, nicotinamide adenine dinucleotide phosphate oxidase-4, and malondialdehyde levels of the patient group were statistically significantly higher than those of the control group (<i>P</i> < .001). Statistically significant positive correlations were detected between the serum nicotinamide adenine dinucleotide phosphate oxidase-2 and nicotinamide adenine dinucleotide phosphate oxidase-4 levels (<i>r</i> = 0.692, <i>P</i> = .001) and between the serum nicotinamide adenine dinucleotide phosphate oxidase-2 and malondialdehyde levels (<i>r</i> = 0.563, <i>P</i> = .001).</p><p><strong>Conclusion: </strong>The results of this study indicated that oxidative stress and lipid peroxidation levels were higher in obsessive-compulsive disorder patients. Based on this finding, NOX-2 and NOX-4 levels can be used as indicators of endogenous oxidative stress in obsessive-compulsive disorder patients.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099616/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89837898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antinuclear Antibodies and Thyroid Autoantibodies in the Serum of Chinese Patients with Acute Psychiatric Disorders: A Retrospective Study. 中国急性精神障碍患者血清中的抗核抗体和甲状腺自身抗体:一项回顾性研究
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.22005
Ying-Bo Rao, Chen Cheng, Yun-Rong Lu, Wei-Gen Wu, Xiao-Ping Xia

Background: It has been shown that autoimmune diseases are associated with psychiatric disorders in epidemiological studies. The acute psychiatric disorder patients have higher frequency of autoantibodies in the blood, including antinuclear antibodies, anti-thyroid peroxidase, and thyroglobulin [thyroid antibody carriers]. However, large clinical studies with more relevant control groups in China are few.

Methods: This was a retrospective study. A total of 1669 sera were tested for autoantibodies in the clinical laboratory of the Fourth Affiliated Hospital, Zhejiang University School of Medicine from October 2016 to March 2021. All data available during this time period were analyzed. Only the first entry for each patient from inpatient care units was used for analysis. The clinical information and laboratory data of patients were retrospectively collected and analyzed.

Results: A significantly lower prevalence of antinuclear antibodies was observed in the healthy control group than in the patient group (21.7% vs 28.8%, P < .05). There was a significant difference in the prevalence of antinuclear antibodies between thyroglobulin-antibody carriers and thyroid peroxidase-antibody- and thyroglobulin-antibody-seronegative individuals in the unipolar depressive disorder group (P < .05). A positive anti-thyroid peroxidase test was significantly associated with patients having nonaffective psychoses (P < .05).

Conclusion: The results showed that psychiatric disorders were associated with antinuclear antibodies and thyroid autoantibodies in our large sample of patients admitted to acute psychiatric hospitalization, and autoimmune autoantibodies were potential biomarkers of psychotic disorders. The results might lead to new research directions for the study of psychiatric disorders in the future.

背景:流行病学研究表明,自身免疫性疾病与精神障碍有关。急性精神障碍患者血液中自身抗体的发生率较高,包括抗核抗体、抗甲状腺过氧化物酶和甲状腺球蛋白(甲状腺抗体携带者)。然而,在中国,有更多相关对照组的大型临床研究还很少:本研究为回顾性研究。自2016年10月至2021年3月,浙江大学医学院附属第四医院临床实验室共对1669份血清进行了自身抗体检测。研究人员对这段时间内的所有数据进行了分析。分析时仅使用每位患者在住院治疗科室的首次输入数据。对患者的临床信息和实验室数据进行回顾性收集和分析:结果:健康对照组的抗核抗体患病率明显低于患者组(21.7% vs 28.8%,P < .05)。单极抑郁症组中甲状腺球蛋白抗体携带者与甲状腺过氧化物酶抗体和甲状腺球蛋白抗体阴性者之间的抗核抗体流行率存在明显差异(P < .05)。抗甲状腺过氧化物酶检测呈阳性与非情感性精神病患者显著相关(P < .05):结果表明,在我们的大样本急性精神病住院患者中,精神障碍与抗核抗体和甲状腺自身抗体相关,自身免疫性自身抗体是精神障碍的潜在生物标志物。这些结果可能会为今后的精神病研究带来新的研究方向。
{"title":"Antinuclear Antibodies and Thyroid Autoantibodies in the Serum of Chinese Patients with Acute Psychiatric Disorders: A Retrospective Study.","authors":"Ying-Bo Rao, Chen Cheng, Yun-Rong Lu, Wei-Gen Wu, Xiao-Ping Xia","doi":"10.5152/pcp.2022.22005","DOIUrl":"10.5152/pcp.2022.22005","url":null,"abstract":"<p><strong>Background: </strong>It has been shown that autoimmune diseases are associated with psychiatric disorders in epidemiological studies. The acute psychiatric disorder patients have higher frequency of autoantibodies in the blood, including antinuclear antibodies, anti-thyroid peroxidase, and thyroglobulin [thyroid antibody carriers]. However, large clinical studies with more relevant control groups in China are few.</p><p><strong>Methods: </strong>This was a retrospective study. A total of 1669 sera were tested for autoantibodies in the clinical laboratory of the Fourth Affiliated Hospital, Zhejiang University School of Medicine from October 2016 to March 2021. All data available during this time period were analyzed. Only the first entry for each patient from inpatient care units was used for analysis. The clinical information and laboratory data of patients were retrospectively collected and analyzed.</p><p><strong>Results: </strong>A significantly lower prevalence of antinuclear antibodies was observed in the healthy control group than in the patient group (21.7% vs 28.8%, <i>P</i> < .05). There was a significant difference in the prevalence of antinuclear antibodies between thyroglobulin-antibody carriers and thyroid peroxidase-antibody- and thyroglobulin-antibody-seronegative individuals in the unipolar depressive disorder group (<i>P</i> < .05). A positive anti-thyroid peroxidase test was significantly associated with patients having nonaffective psychoses (<i>P</i> < .05).</p><p><strong>Conclusion: </strong>The results showed that psychiatric disorders were associated with antinuclear antibodies and thyroid autoantibodies in our large sample of patients admitted to acute psychiatric hospitalization, and autoimmune autoantibodies were potential biomarkers of psychotic disorders. The results might lead to new research directions for the study of psychiatric disorders in the future.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75174899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depression, But Not Dissociative Experiences, Predicts Overgeneral Memory: A Systematic Review and Meta-Regression Analysis. 抑郁(而非分离体验)可预测过度总体记忆:系统回顾与元回归分析》。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.21285
Ayşenur Okan, Fatma Aydın, Mahmut Alp Erkent, Vedat Sar, Sami Gülgöz, Hale Yapıcı Eser

Background: Reduced memory specificity (i.e., overgeneral memory) is a characteristic of autobiographical memories widely studied in clinical populations, and it is explained by rumination, functional avoidance, and executive dysfunction. Though the relationship of autobiographical memory specificity with mood and anxiety disorders has been shown, how it relates to dissociation is not well-established. Thus, we aimed to investigate whether dissociative experiences are related to overgeneral memory while considering concurrent depression as a possible confounding factor.

Methods: We conducted a systematic review in compliance with The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines and searched PubMed and Web of Science databases using autobiograph* and dissoc* as our keywords.

Results: Of the 768 studies identified, 9 studies fulfilled the inclusion criteria. A meta-regression analysis was conducted to analyze the relationship between dissociative experiences and depression scores with autobiographical memory test scores. Our research revealed that depression scores, but not dissociative experiences, are significantly related to reduced memory specificity.

Conclusion: While the possible overlap between dissociation and depression should be considered in the interpretation of the findings, dissociative experiences do not seem to pose vulnerability for reduced specificity of autobiographical memory. The number of studies on the topic is limited, and they do not have longitudinal follow-ups. The heterogeneous reporting of memory scores and low scores of dissociative experiences in the samples are also limitations of the existing studies.

背景:记忆特异性降低(即记忆过于笼统)是临床人群广泛研究的自传体记忆的一个特征,反刍、功能性回避和执行功能障碍可以解释这一特征。虽然自传体记忆特异性与情绪和焦虑症的关系已经得到证实,但它与解离之间的关系还没有得到很好的证实。因此,我们旨在研究解离体验是否与过度概括记忆有关,同时考虑并发抑郁症这一可能的混杂因素:我们按照《系统综述和元分析首选报告项目》(PRISMA)指南进行了系统综述,并以自传*和解离*为关键词在PubMed和Web of Science数据库中进行了检索:在确定的 768 项研究中,有 9 项研究符合纳入标准。我们进行了元回归分析,以分析解离体验和抑郁评分与自传体记忆测试评分之间的关系。我们的研究发现,抑郁评分与记忆特异性降低有显著关系,但与解离体验无关:结论:虽然在解释研究结果时应考虑解离和抑郁之间可能存在的重叠,但解离体验似乎并不构成自传体记忆特异性降低的脆弱性。有关该主题的研究数量有限,而且没有进行纵向跟踪。现有研究的局限性还包括记忆评分报告的不一致以及样本中分离性经历的评分较低。
{"title":"Depression, But Not Dissociative Experiences, Predicts Overgeneral Memory: A Systematic Review and Meta-Regression Analysis.","authors":"Ayşenur Okan, Fatma Aydın, Mahmut Alp Erkent, Vedat Sar, Sami Gülgöz, Hale Yapıcı Eser","doi":"10.5152/pcp.2022.21285","DOIUrl":"10.5152/pcp.2022.21285","url":null,"abstract":"<p><strong>Background: </strong>Reduced memory specificity (i.e., overgeneral memory) is a characteristic of autobiographical memories widely studied in clinical populations, and it is explained by rumination, functional avoidance, and executive dysfunction. Though the relationship of autobiographical memory specificity with mood and anxiety disorders has been shown, how it relates to dissociation is not well-established. Thus, we aimed to investigate whether dissociative experiences are related to overgeneral memory while considering concurrent depression as a possible confounding factor.</p><p><strong>Methods: </strong>We conducted a systematic review in compliance with The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines and searched PubMed and Web of Science databases using autobiograph* and dissoc* as our keywords.</p><p><strong>Results: </strong>Of the 768 studies identified, 9 studies fulfilled the inclusion criteria. A meta-regression analysis was conducted to analyze the relationship between dissociative experiences and depression scores with autobiographical memory test scores. Our research revealed that depression scores, but not dissociative experiences, are significantly related to reduced memory specificity.</p><p><strong>Conclusion: </strong>While the possible overlap between dissociation and depression should be considered in the interpretation of the findings, dissociative experiences do not seem to pose vulnerability for reduced specificity of autobiographical memory. The number of studies on the topic is limited, and they do not have longitudinal follow-ups. The heterogeneous reporting of memory scores and low scores of dissociative experiences in the samples are also limitations of the existing studies.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099643/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90050925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulation of Antidepressant Prescription for the Effective Treatment of Mental Disorders in Turkey: A Narrative Review. 土耳其规范抗抑郁药物处方以有效治疗精神障碍:叙述性综述》。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.22408
Sophia Bahar Root, Elizabeth Clarey

Background: This non-systematic narrative review aims to summarize the results of clinical studies evaluating the effectiveness of antidepressants used to treat mental illnesses including major depressive disorder, obsessive-compulsive disorder, somatization disorder, and anxiety disorders in Turkey. Conclusions drawn from this article can guide ongoing efforts by Turkish health policymakers to improve public health development in the country by further regulating the prescription of antidepressants.

Methods: Relevant articles regarding the effectiveness of antidepressant use were collected in June 2021 using Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus and Academic Search Complete online databases. The collected articles were then appraised using the Critical Appraisal Skills Programme to determine the reliability and quality of each article and to assess the risk of bias in each article. The summary of key findings/evidence, Critical Appraisal Skills Programme appraisal summary results, funding, study designs applied, settings covered, period covered (years), and additional comments were extracted from each article for analysis. The inclusion criteria involved articles that recounted adverse effects and effectiveness of antidepressant use in Turkey to treat mental illnesses, including anxiety disorders, major depressive disorder, somatization disorder, and obsessive-compulsive disorder. The exclusion criteria consisted of articles that included participants who resided outside of the geographic region of Turkey, abstracts, the pharmacology of antidepressant use, antidepressant off-label use, and alternative treatments.

Results: A total of 15 articles out of the 104 derived from the databases were included in the study that fell into 1 of the following main themes, "adverse effects" and "mixed results," which accounted for 53% (8 articles) and 40% (6 articles), respectively. One outlying article was identified (7%).

Conclusions: Totally 8 out of 15 articles that recounted antidepressants prescribed for mental illnesses produced adverse effects without treatment success and 6 out of 15 articles recounted adverse effects with treatment success. One outlying article found a confound that precluded determining whether an adverse effect was caused by antidepressant use or confounded by pre-existing conditions. Given that 14 out of 15 articles recounted adverse effects associated with antidepressant use and 6 out of 15 articles recounted antidepressant treatment success, Turkish policymakers are encouraged to adopt a restrictive drug policy strategy. To sum up, antidepressant prescription and consumption should be conducted with caution to limit unnecessary risk of exposure to adverse effects associated with antidepressant use. Limitations in the research included using a non-systematic tool instead of conducting a systematic review, a li

背景:这篇非系统性叙事综述旨在总结土耳其用于治疗重度抑郁症、强迫症、躯体化障碍和焦虑症等精神疾病的抗抑郁药有效性的临床研究评估结果。本文得出的结论可指导土耳其卫生决策者通过进一步规范抗抑郁药的处方来改善该国的公共卫生发展:方法:2021 年 6 月,使用《护理及相关保健文献累积索引》(CINAHL)Plus 和《学术搜索全文》在线数据库收集了有关抗抑郁药使用效果的相关文章。然后使用 "批判性评估技能计划 "对收集到的文章进行评估,以确定每篇文章的可靠性和质量,并评估每篇文章的偏倚风险。从每篇文章中提取关键发现/证据摘要、关键评估技能计划评估结果摘要、资金、应用的研究设计、涵盖的环境、涵盖的时间(年)以及附加评论进行分析。纳入标准包括叙述在土耳其使用抗抑郁药治疗精神疾病(包括焦虑症、重度抑郁症、躯体化障碍和强迫症)的不良反应和有效性的文章。排除标准包括包含居住在土耳其地理区域以外的参与者的文章、摘要、抗抑郁药的药理学使用、抗抑郁药的标示外使用以及替代疗法:从数据库中提取的 104 篇文章中,共有 15 篇文章被纳入研究,它们属于以下两个主题中的一个:"不良反应 "和 "混合结果",分别占 53%(8 篇)和 40%(6 篇)。结论:在 15 篇文章中,共有 8 篇文章提到了 "不良反应 "和 "混合结果":结论:在 15 篇文章中,有 8 篇文章叙述了抗抑郁药物治疗精神疾病产生的不良反应,但没有取得治疗成功;有 6 篇文章叙述了不良反应,但取得了治疗成功。有一篇文章发现了一个混淆因素,从而无法确定不良反应是由使用抗抑郁药引起的,还是由之前存在的病症造成的。鉴于 15 篇文章中有 14 篇叙述了与使用抗抑郁药有关的不良反应,15 篇文章中有 6 篇叙述了抗抑郁药治疗的成功,因此鼓励土耳其决策者采取限制性药物政策战略。总之,在开具和服用抗抑郁药时应谨慎从事,以减少不必要的抗抑郁药不良反应风险。研究的局限性包括:使用了非系统性工具而非进行系统性综述;文章数量有限(104 篇文章中只有 15 篇);通过 "批判性评估技能计划 "对文章进行评估后发现存在偏倚风险。
{"title":"Regulation of Antidepressant Prescription for the Effective Treatment of Mental Disorders in Turkey: A Narrative Review.","authors":"Sophia Bahar Root, Elizabeth Clarey","doi":"10.5152/pcp.2022.22408","DOIUrl":"10.5152/pcp.2022.22408","url":null,"abstract":"<p><strong>Background: </strong>This non-systematic narrative review aims to summarize the results of clinical studies evaluating the effectiveness of antidepressants used to treat mental illnesses including major depressive disorder, obsessive-compulsive disorder, somatization disorder, and anxiety disorders in Turkey. Conclusions drawn from this article can guide ongoing efforts by Turkish health policymakers to improve public health development in the country by further regulating the prescription of antidepressants.</p><p><strong>Methods: </strong>Relevant articles regarding the effectiveness of antidepressant use were collected in June 2021 using Cumulative Index to Nursing and Allied Health Literature (CINAHL) Plus and Academic Search Complete online databases. The collected articles were then appraised using the Critical Appraisal Skills Programme to determine the reliability and quality of each article and to assess the risk of bias in each article. The summary of key findings/evidence, Critical Appraisal Skills Programme appraisal summary results, funding, study designs applied, settings covered, period covered (years), and additional comments were extracted from each article for analysis. The inclusion criteria involved articles that recounted adverse effects and effectiveness of antidepressant use in Turkey to treat mental illnesses, including anxiety disorders, major depressive disorder, somatization disorder, and obsessive-compulsive disorder. The exclusion criteria consisted of articles that included participants who resided outside of the geographic region of Turkey, abstracts, the pharmacology of antidepressant use, antidepressant off-label use, and alternative treatments.</p><p><strong>Results: </strong>A total of 15 articles out of the 104 derived from the databases were included in the study that fell into 1 of the following main themes, \"adverse effects\" and \"mixed results,\" which accounted for 53% (8 articles) and 40% (6 articles), respectively. One outlying article was identified (7%).</p><p><strong>Conclusions: </strong>Totally 8 out of 15 articles that recounted antidepressants prescribed for mental illnesses produced adverse effects without treatment success and 6 out of 15 articles recounted adverse effects with treatment success. One outlying article found a confound that precluded determining whether an adverse effect was caused by antidepressant use or confounded by pre-existing conditions. Given that 14 out of 15 articles recounted adverse effects associated with antidepressant use and 6 out of 15 articles recounted antidepressant treatment success, Turkish policymakers are encouraged to adopt a restrictive drug policy strategy. To sum up, antidepressant prescription and consumption should be conducted with caution to limit unnecessary risk of exposure to adverse effects associated with antidepressant use. Limitations in the research included using a non-systematic tool instead of conducting a systematic review, a li","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099634/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83672078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Klotho and FGF23 Levels in Patients with Schizophrenia. 精神分裂症患者的血清 Klotho 和 FGF23 水平。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.22406
Aslı Kazgan Kılıçaslan, Sevler Yıldız, Burcu Sırlıer Emir, Faruk Kılıç, Murad Atmaca

Background: The aim of this study is to compare the serum levels of Klotho and fibroblast growth factor 23 in patients with schizophrenia, in whom etiopathogenesis inflammation plays an important role, with those of healthy control subjects and to investigate a possible correlation between these levels.

Methods: Forty male patients with schizophrenia and 40 healthy male control subjects who were followed up and/or treated at the High-Security Forensic Psychiatry Clinic participated in the study. Sociodemographic data form, the Positive and Negative Syndrome Scale, and the Clinical Global Impression Scale were collected from all subjects, and participants' fibroblast growth factor 23 and Klotho serum levels were measured by the enzyme-linked immunosorbent assay method.

Results: The serum levels of Klotho and fibroblast growth factor 23 were significantly higher in schizophrenia patients than in healthy controls (P  = .048 and P  = .010, respectively). A significant positive correlation was observed between serum levels of Klotho and fibroblast growth factor 23 in subjects (r = 0.816; P  < .001).

Conclusion: Our study is the first to show significantly higher combined serum levels of fibroblast growth factor 23 and Klotho in patients with schizophrenia. The Klotho/fibroblast growth factor 23 pathway may play a role in the pathogenesis of schizophrenia. The involvement of Klotho and fibroblast growth factor 23 in inflammatory processes has the potential to provide alternative approaches to elucidate the etiopathogenesis and treatment of schizophrenia.

研究背景本研究的目的是比较精神分裂症患者血清中Klotho和成纤维细胞生长因子23的水平(炎症在精神分裂症的发病机制中起着重要作用),以及健康对照受试者血清中Klotho和成纤维细胞生长因子23的水平,并研究这些水平之间可能存在的相关性:参加研究的有 40 名男性精神分裂症患者和 40 名健康男性对照组受试者,他们都在高度警戒法医精神病诊所接受过随访和/或治疗。研究人员收集了所有受试者的社会人口学数据表、阳性和阴性综合征量表以及临床总体印象量表,并采用酶联免疫吸附法测定了受试者的成纤维细胞生长因子23和Klotho血清水平:结果:精神分裂症患者血清中 Klotho 和成纤维细胞生长因子 23 的水平明显高于健康对照组(P = .048 和 P = .010)。受试者血清中Klotho和成纤维细胞生长因子23的水平之间存在明显的正相关性(r = 0.816; P < .001):我们的研究首次显示,精神分裂症患者血清中成纤维细胞生长因子23和Klotho的综合水平明显较高。Klotho/成纤维细胞生长因子23通路可能在精神分裂症的发病机制中发挥作用。Klotho和成纤维细胞生长因子23参与炎症过程有可能为阐明精神分裂症的发病机制和治疗提供另一种方法。
{"title":"Serum Klotho and FGF23 Levels in Patients with Schizophrenia.","authors":"Aslı Kazgan Kılıçaslan, Sevler Yıldız, Burcu Sırlıer Emir, Faruk Kılıç, Murad Atmaca","doi":"10.5152/pcp.2022.22406","DOIUrl":"10.5152/pcp.2022.22406","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study is to compare the serum levels of Klotho and fibroblast growth factor 23 in patients with schizophrenia, in whom etiopathogenesis inflammation plays an important role, with those of healthy control subjects and to investigate a possible correlation between these levels.</p><p><strong>Methods: </strong>Forty male patients with schizophrenia and 40 healthy male control subjects who were followed up and/or treated at the High-Security Forensic Psychiatry Clinic participated in the study. Sociodemographic data form, the Positive and Negative Syndrome Scale, and the Clinical Global Impression Scale were collected from all subjects, and participants' fibroblast growth factor 23 and Klotho serum levels were measured by the enzyme-linked immunosorbent assay method.</p><p><strong>Results: </strong>The serum levels of Klotho and fibroblast growth factor 23 were significantly higher in schizophrenia patients than in healthy controls (<i>P</i>  = .048 and <i>P</i>  = .010, respectively). A significant positive correlation was observed between serum levels of Klotho and fibroblast growth factor 23 in subjects (<i>r</i> = 0.816; <i>P</i>  < .001).</p><p><strong>Conclusion: </strong>Our study is the first to show significantly higher combined serum levels of fibroblast growth factor 23 and Klotho in patients with schizophrenia. The Klotho/fibroblast growth factor 23 pathway may play a role in the pathogenesis of schizophrenia. The involvement of Klotho and fibroblast growth factor 23 in inflammatory processes has the potential to provide alternative approaches to elucidate the etiopathogenesis and treatment of schizophrenia.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099619/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78741773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users. 医用大麻药房使用者样本中与有问题的大麻使用相关的因素。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.22358
Lindsay A Lo, Caroline A MacCallum, Jade C Yau, William J Panenka, Alasdair M Barr

Background: With the recent legalization of cannabis for medical purposes in many countries, there has been an increased number of individuals using such products. While there is considerable evidence indicating that cannabis may have therapeutic effects for a range of different conditions, concerns remain about the risk of developing cannabis use disorders for those at risk, or patients without appropriate clinical guidance. The aim of the present study was to determine the prevalence of problematic cannabis use in a cohort of cannabis users who consumed the drug for medical purposes and to identify potential risk factors.

Methods: One hundred individuals who self-identified as using cannabis to improve their mental health were recruited from a community dispensary. Extensive details were collected about subjects' patterns of cannabis use and reasons for use. All subjects completed a structured clinical interview with the Mini-International Neuropsychiatric Interview, while information about perceived stress, depressive symptoms, and somatic symptoms were recorded with the Perceived Stress Scale-10, Beck Depression Inventory, and the Patient Health Questionnaire-15.

Results: Rates of problematic cannabis use were high, with 30% meeting the criteria. Only 10% of subjects reported medical cannabis use was recommended by their doctor. Significant risk factors for problematic use included earlier age of cannabis initiation, as well as self-reported use of cannabis products for depression.

Conclusions: The prevalence of problematic cannabis use in the community dispensary was higher than expected. Specific risk factors for problematic cannabis use may represent important areas for future intervention to ensure safer consumption for medical purposes.

背景:随着最近许多国家将用于医疗目的的大麻合法化,越来越多的人开始使用这类产品。虽然有大量证据表明大麻可能对一系列不同病症有治疗作用,但对于那些高危人群或没有适当临床指导的患者来说,大麻使用障碍的发病风险仍然令人担忧。本研究旨在确定以医疗为目的吸食大麻的大麻使用者群体中问题大麻使用的流行率,并找出潜在的风险因素:从一家社区药房招募了 100 名自我认定使用大麻改善精神健康的人。收集了受试者使用大麻的模式和原因的大量详细信息。所有受试者都完成了迷你国际神经精神访谈(Mini-International Neuropsychiatric Interview)的结构化临床访谈,同时使用感知压力量表(Perceived Stress Scale-10)、贝克抑郁量表(Beck Depression Inventory)和患者健康问卷(Patient Health Questionnaire-15)记录了有关感知压力、抑郁症状和躯体症状的信息:有问题的大麻使用率很高,有 30% 符合标准。只有 10%的受试者称使用医用大麻是在医生的建议下进行的。使用问题大麻的重要风险因素包括开始使用大麻的年龄较早,以及自我报告使用大麻产品治疗抑郁症:结论:在社区药房使用问题大麻的流行率高于预期。使用问题大麻的特定风险因素可能是未来进行干预的重要领域,以确保更安全的医疗消费。
{"title":"Factors Associated with Problematic Cannabis Use in a Sample of Medical Cannabis Dispensary Users.","authors":"Lindsay A Lo, Caroline A MacCallum, Jade C Yau, William J Panenka, Alasdair M Barr","doi":"10.5152/pcp.2022.22358","DOIUrl":"10.5152/pcp.2022.22358","url":null,"abstract":"<p><strong>Background: </strong>With the recent legalization of cannabis for medical purposes in many countries, there has been an increased number of individuals using such products. While there is considerable evidence indicating that cannabis may have therapeutic effects for a range of different conditions, concerns remain about the risk of developing cannabis use disorders for those at risk, or patients without appropriate clinical guidance. The aim of the present study was to determine the prevalence of problematic cannabis use in a cohort of cannabis users who consumed the drug for medical purposes and to identify potential risk factors.</p><p><strong>Methods: </strong>One hundred individuals who self-identified as using cannabis to improve their mental health were recruited from a community dispensary. Extensive details were collected about subjects' patterns of cannabis use and reasons for use. All subjects completed a structured clinical interview with the Mini-International Neuropsychiatric Interview, while information about perceived stress, depressive symptoms, and somatic symptoms were recorded with the Perceived Stress Scale-10, Beck Depression Inventory, and the Patient Health Questionnaire-15.</p><p><strong>Results: </strong>Rates of problematic cannabis use were high, with 30% meeting the criteria. Only 10% of subjects reported medical cannabis use was recommended by their doctor. Significant risk factors for problematic use included earlier age of cannabis initiation, as well as self-reported use of cannabis products for depression.</p><p><strong>Conclusions: </strong>The prevalence of problematic cannabis use in the community dispensary was higher than expected. Specific risk factors for problematic cannabis use may represent important areas for future intervention to ensure safer consumption for medical purposes.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099647/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84424472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Factor Structure of the Hospital Anxiety Depression Scale Adapted for Korean Preschool Teacher Candidates During the Coronavirus Disease 2019 Pandemic. 医院焦虑抑郁量表的因子结构》,改编自 "2019年冠状病毒病大流行期间韩国学前教育专业应聘教师问卷"。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2022-09-01 DOI: 10.5152/pcp.2022.22426
Hyelin Jeong, Boram Lee

Background: The coronavirus disease 2019 pandemic has remarkably challenged preschool teacher candidates, triggering concerns for their psychological well-being and mental health. Valid and reliable instruments to assess elements of mental health are thus required. The self-rating Hospital Anxiety Depression Scale demonstrates promise as an instrument for the identification and quantification of the states of anxiety and depression in non-psychiatric patients. The Hospital Anxiety Depression Scale is widely applied in both clinical and research contexts. However, no psychometric evaluations have been performed for this instrument with non-clinical samples such as preschool teacher candidates in South Korea. This study purposed to establish the factor structure of the Hospital Anxiety Depression Scale and to validate its Korean version and was conducted online with a sample of preschool teacher candidates during the peak of the coronavirus disease 2019 lockdown.

Methods: Data were collected from 359 undergraduates currently enrolled in a 4-year early childhood education degree program at a private university in Korea. The sample was randomly split to perform exploratory factor analysis and then confirmatory factor analysis respectively to test competing models hypothesized to reflect the factor structure of the Hospital Anxiety Depression Scale.

Results: Supplemental revisions based on confirmatory factor analysis modification indices demonstrated that a correlated 2-factor model with 1 cross-loaded item offered the best fit to the data with adequate internal reliability estimates.

Conclusion: Overall, this study confirms the validity and factor structure of the Korean version of the Hospital Anxiety Depression Scale, which is deemed an acceptable instrument that can be used to measure the symptoms of depression and anxiety in Korean preschool teacher candidates.

背景:2019 年冠状病毒疾病大流行给学前教育师范生带来了极大的挑战,引发了人们对其心理健康和精神健康的关注。因此,需要有效、可靠的工具来评估心理健康要素。医院焦虑抑郁自评量表作为一种用于识别和量化非精神病患者焦虑和抑郁状态的工具,显示了其前景。医院焦虑抑郁量表被广泛应用于临床和研究领域。然而,目前还没有针对非临床样本(如韩国的学前教育师范生)对该量表进行心理测量学评估。本研究旨在建立医院焦虑抑郁量表的因子结构,并验证其韩国版本,在2019年冠状病毒病封锁高峰期对学前教育师范生样本进行了在线测试:数据收集自韩国一所私立大学四年制幼儿教育专业的359名本科生。随机拆分样本,分别进行探索性因子分析和确认性因子分析,以检验假设反映医院焦虑抑郁量表因子结构的竞争模型:根据确认性因素分析修正指数进行的补充修订表明,带有 1 个交叉负荷项目的相关 2 因子模型与数据的拟合度最高,且内部信度估计值充足:总之,本研究证实了韩国版医院焦虑抑郁量表的有效性和因素结构,认为它是一种可接受的工具,可用于测量韩国学前教育师范生的抑郁和焦虑症状。
{"title":"The Factor Structure of the Hospital Anxiety Depression Scale Adapted for Korean Preschool Teacher Candidates During the Coronavirus Disease 2019 Pandemic.","authors":"Hyelin Jeong, Boram Lee","doi":"10.5152/pcp.2022.22426","DOIUrl":"10.5152/pcp.2022.22426","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 pandemic has remarkably challenged preschool teacher candidates, triggering concerns for their psychological well-being and mental health. Valid and reliable instruments to assess elements of mental health are thus required. The self-rating Hospital Anxiety Depression Scale demonstrates promise as an instrument for the identification and quantification of the states of anxiety and depression in non-psychiatric patients. The Hospital Anxiety Depression Scale is widely applied in both clinical and research contexts. However, no psychometric evaluations have been performed for this instrument with non-clinical samples such as preschool teacher candidates in South Korea. This study purposed to establish the factor structure of the Hospital Anxiety Depression Scale and to validate its Korean version and was conducted online with a sample of preschool teacher candidates during the peak of the coronavirus disease 2019 lockdown.</p><p><strong>Methods: </strong>Data were collected from 359 undergraduates currently enrolled in a 4-year early childhood education degree program at a private university in Korea. The sample was randomly split to perform exploratory factor analysis and then confirmatory factor analysis respectively to test competing models hypothesized to reflect the factor structure of the Hospital Anxiety Depression Scale.</p><p><strong>Results: </strong>Supplemental revisions based on confirmatory factor analysis modification indices demonstrated that a correlated 2-factor model with 1 cross-loaded item offered the best fit to the data with adequate internal reliability estimates.</p><p><strong>Conclusion: </strong>Overall, this study confirms the validity and factor structure of the Korean version of the Hospital Anxiety Depression Scale, which is deemed an acceptable instrument that can be used to measure the symptoms of depression and anxiety in Korean preschool teacher candidates.</p>","PeriodicalId":20847,"journal":{"name":"Psychiatry and Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11099641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84829084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Psychiatry and Clinical Psychopharmacology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1